Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 33841-33842 [2013-13284]

Download as PDF Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Applicants The Commission gives notice that the following applicants have filed an application for an Ocean Transportation Intermediary (OTI) license as a NonVessel-Operating Common Carrier (NVO) and/or Ocean Freight Forwarder (OFF) pursuant to section 19 of the Shipping Act of 1984 (46 U.S.C. 40101). Notice is also given of the filing of applications to amend an existing OTI license or the Qualifying Individual (QI) for a licensee. Interested persons may contact the Office of Ocean Transportation Intermediaries, Federal Maritime Commission, Washington, DC 20573, by telephone at (202) 523–5843 or by email at OTI@fmc.gov. CFR Rinkens, LLC dba Rinkens International dba CFR Line (NVO), 15501 Texaco Avenue, Paramount, CA 90723, Officers: Maximiliaan Hoes, Manager (QI), Michele Blackmore, Vice President, Application Type: Add NVO Service. Javelin Logistics Corporation (NVO & OFF), 7447A Morton Avenue, Newark, CA 94560, Officers: Susan M. Foster, International Services (QI), Malcolm Winspear, President, Application Type: QI Change. Sig Global, Inc. (NVO & OFF), 16012 S. Western Avenue, Suite 300, Gardena, CA 90247, Officers: James J. Oh, President (QI), Chung Kwon Kim, Secretary, Application Type: New NVO & OFF License. Super You Global (NVO & OFF), 391 Curtner Avenue, Suite 1, Palo Alto, CA 94306, Officers: Hu Wang, CEO (QI), Xin You, President, Application Type: New NVO & OFF License. Windstream International Inc. (NVO & OFF), 2001 Santa Anita Avenue, Suite 203A, South El Monte, CA 91733, Officer: Jeff C. Chang, CEO (QI), Application Type: New NVO & OFF License. By the Commission. Dated: May 31, 2013. Rachel E. Dickon, Assistant Secretary. mstockstill on DSK4VPTVN1PROD with NOTICES BILLING CODE 6730–01–P FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Revocations The Commission gives notice that the following Ocean Transportation Intermediary licenses have been VerDate Mar<15>2010 16:43 Jun 04, 2013 Jkt 229001 revoked pursuant to section 19 of the Shipping Act of 1984 (46 U.S.C. 40101) effective on the date shown. License No.: 3642F. Name: Honeybee International Forwarding. Address: 2301 S. Tubeway Avenue, Commerce, CA 90040. Date Revoked: May 16, 2013. Reason: Voluntary Surrender of License. License No.: 015890NF. Name: OEC Freight Chicago, Inc. Address: 501 Frontier Way, Bensenville, IL 60106. Date Revoked: May 6, 2013. Reason: Voluntary Surrender of License. License No.: 021796NF. Name: Keith Phillips Transportation, LLC. Address: 124 Garden Gate Drive, Ponte Vedra Beach, FL 32082. Date Revoked: May 15, 2013. Reason: Voluntary Surrender of License. License No.: 021952NF. Name: Streamline Trade Management Inc. dba Teamwork Logistic. Address: 177–25 Rockaway Blvd. Suite 213, Jamaica, NY 11434. Date Revoked: May 9, 2013. Reason: Voluntary Surrender of License. License No.: 023793NF. Name: Interlink Cargo Logistics, LLC. Address: 76 Loy Avenue, Riverdale, NJ 07457. Date Revoked: May 14, 2013. Reason: Voluntary Surrender of License. Consistent with its statutory mandate, the Federal Open Market Committee seeks monetary and financial conditions that will foster maximum employment and price stability. In particular, the Committee seeks conditions in reserve markets consistent with federal funds trading in a range from 0 to 1⁄4 percent. The Committee directs the Desk to undertake open market operations as necessary to maintain such conditions. The Desk is directed to continue purchasing longer-term Treasury securities at a pace of about $45 billion per month and to continue purchasing agency mortgage-backed securities at a pace of about $40 billion per month. The Committee also directs the Desk to engage in dollar roll and coupon swap transactions as necessary to facilitate settlement of the Federal Reserve’s agency mortgage-backed securities transactions. The Committee directs the Desk to maintain its policy of rolling over maturing Treasury securities into new issues and its policy of reinvesting principal payments on all agency debt and agency mortgage-backed securities in agency mortgage-backed securities. The System Open Market Account Manager and the Secretary will keep the Committee informed of ongoing developments regarding the System’s balance sheet that could affect the attainment over time of the Committee’s objectives of maximum employment and price stability. James A. Nussbaumer, Deputy Director, Bureau of Certification and Licensing. BILLING CODE 6210–01–P [FR Doc. 2013–13327 Filed 6–4–13; 8:45 am] By order of the Federal Open Market Committee, May 23, 2013. William B. English, Secretary, Federal Open Market Committee. [FR Doc. 2013–13271 Filed 6–4–13; 8:45 am] FEDERAL RESERVE SYSTEM BILLING CODE 6730–01–P Formations of, Acquisitions by, and Mergers of Bank Holding Companies FEDERAL RESERVE SYSTEM The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Federal Open Market Committee; Domestic Policy Directive of April 30– May 1, 2013 In accordance with Section 271.25 of its rules regarding availability of information (12 CFR part 271), there is set forth below the domestic policy directive issued by the Federal Open Market Committee at its meeting held on April 30–May 1, 2013.1 [FR Doc. 2013–13325 Filed 6–4–13; 8:45 am] 33841 1 Copies of the Minutes of the Federal Open Market Committee at its meeting held on April 30– May 1, 2013, which includes the domestic policy directive issued at the meeting, are available upon request to the Board of Governors of the Federal Reserve System, Washington, DC 20551. The PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 minutes are published in the Federal Reserve Bulletin and in the Board’s Annual Report. E:\FR\FM\05JNN1.SGM 05JNN1 33842 Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than July 1, 2013. A. Federal Reserve Bank of Boston (Richard Walker, Community Affairs Officer) 600 Atlantic Avenue, Boston, Massachusetts 02210–2204: 1. Hometown Community Bancorp, MHC, Oxford, Massachusetts; to acquire 100 percent of the voting shares of Hometown Community Bancorp, Inc., Oxford, Massachusetts, which will acquire Hometown Bank, A Cooperative Bank, Webster, Massachusetts. In addition, Hometown Community Bancorp, Inc., Oxford, Massachusetts, also has applied to become a bank holding company, by acquiring Hometown Bank, A Cooperative Bank, Webster, Massachusetts. Board of Governors of the Federal Reserve System, May 31, 2013. Margaret McCloskey Shanks, Deputy Secretary of the Board. [FR Doc. 2013–13284 Filed 6–4–13; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Determination and Declaration Regarding Emergency Use of In Vitro Diagnostics for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Office of the Secretary, Department of Health and Human Services. ACTION: Notice. mstockstill on DSK4VPTVN1PROD with NOTICES AGENCY: SUMMARY: The Secretary of Health and Human Services (HHS) is issuing this notice pursuant to section 564 of the Federal Food, Drug, and Cosmetic (FD&C) Act, 21 U.S.C. 360bbb–3. On May 29, 2013, the Secretary determined that there is a significant potential for a public health emergency that has a significant potential to affect national VerDate Mar<15>2010 16:43 Jun 04, 2013 Jkt 229001 security or the health and security of United States citizens living abroad and that involves Middle East respiratory syndrome coronavirus (MERS-CoV). On the basis of this determination, she also declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) pursuant to section 564 of the FD&C Act, subject to the terms of any authorization issued under that section. DATES: The determination and declaration are effective May 29, 2013. FOR FURTHER INFORMATION CONTACT: Nicole Lurie, M.D., MSPH, Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, 200 Independence Avenue SW., Washington, DC 20201, Telephone (202) 205–2882 (this is not a toll free number). SUPPLEMENTARY INFORMATION: I. Background Under Section 564 of the FD&C Act, the Commissioner of the Food and Drug Administration (FDA), acting under delegated authority from the Secretary of HHS, may issue an Emergency Use Authorization (EUA) authorizing (1) the emergency use of an unapproved drug, an unapproved or uncleared device, or an unlicensed biological product; or (2) an unapproved use of an approved drug, approved or cleared device, or licensed biological product. Before an EUA may be issued, the Secretary of HHS must declare that circumstances exist justifying the authorization based on one of four determinations: (1) A determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a, chemical, biological, radiological, or nuclear (‘‘CBRN’’) agent or agents; (2) the identification of a material threat by the Secretary of Homeland Security pursuant to section 319F–2 of the Public Health Service (PHS) Act 1 sufficient to affect national security or the health and security of United States citizens living abroad; (3) a determination by the Secretary of Defense that there is a military emergency, or a significant potential for a military emergency, involving a heightened risk to United States military forces of attack with a CBRN agent or agents; or (4) a determination by the Secretary that there is a public health emergency, or a significant potential for 1 42 PO 00000 U.S.C. 247d–6b Frm 00045 Fmt 4703 Sfmt 4703 a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of United States citizens living abroad, and that involves a CBRN agent or agents, or a disease or condition that may be attributable to such agent or agents.2 Based on any of these four determinations, the Secretary of HHS may then declare that circumstances exist that justify the EUA, at which point the FDA Commissioner may issue an EUA if the criteria for issuance of an authorization under section 564 of the FD&C Act are met. The Centers for Disease Control and Prevention (CDC), HHS, requested that the FDA, HHS, issue an EUA for in vitro diagnostics for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) to allow the Department to take preparedness measures based on information currently available about the Middle East respiratory syndrome coronavirus (MERS-CoV). The determination of a significant potential for a public health emergency, and the declaration that circumstances exist justifying emergency use of in vitro diagnostics for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) by the Secretary of HHS, as described below, enable the FDA Commissioner to issue an EUA for certain in vitro diagnostics for emergency use under section 564 of the FD&C Act. II. Determination by the Secretary of Health and Human Services On May 29, 2013, pursuant to section 564 of the FD&C Act, I determined that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad and that involves Middle East respiratory syndrome coronavirus (MERS-CoV). III. Declaration of the Secretary of Health and Human Services Also on May 29, 2013, on the basis of my determination of a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living 2 As amended by the Pandemic and All-Hazards Preparedness Reauthorization Act, Public Law 113– 5, the Secretary may make determination of a public health emergency, or a significant potential for a public health emergency, under section 564 of the FD&C Act. The Secretary is no longer required to make a determination of a public health emergency in accordance with section 319 of the PHS Act, 42 U.S.C. 247d to support a determination or declaration made under section 564 of the FD&C Act. E:\FR\FM\05JNN1.SGM 05JNN1

Agencies

[Federal Register Volume 78, Number 108 (Wednesday, June 5, 2013)]
[Notices]
[Pages 33841-33842]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13284]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The applications listed below, as well as other related filings 
required by the

[[Page 33842]]

Board, are available for immediate inspection at the Federal Reserve 
Bank indicated. The applications will also be available for inspection 
at the offices of the Board of Governors. Interested persons may 
express their views in writing on the standards enumerated in the BHC 
Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition 
of a nonbanking company, the review also includes whether the 
acquisition of the nonbanking company complies with the standards in 
section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, 
nonbanking activities will be conducted throughout the United States.
    Unless otherwise noted, comments regarding each of these 
applications must be received at the Reserve Bank indicated or the 
offices of the Board of Governors not later than July 1, 2013.
    A. Federal Reserve Bank of Boston (Richard Walker, Community 
Affairs Officer) 600 Atlantic Avenue, Boston, Massachusetts 02210-2204:
    1. Hometown Community Bancorp, MHC, Oxford, Massachusetts; to 
acquire 100 percent of the voting shares of Hometown Community Bancorp, 
Inc., Oxford, Massachusetts, which will acquire Hometown Bank, A 
Cooperative Bank, Webster, Massachusetts.
    In addition, Hometown Community Bancorp, Inc., Oxford, 
Massachusetts, also has applied to become a bank holding company, by 
acquiring Hometown Bank, A Cooperative Bank, Webster, Massachusetts.

    Board of Governors of the Federal Reserve System, May 31, 2013.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2013-13284 Filed 6-4-13; 8:45 am]
BILLING CODE 6210-01-P